nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Board
|
|
|
|
25 |
2 |
p. A1-A2 |
artikel |
2 |
Impact of Gut Microbiota on Lymphoma: New Frontiers in Cancer Research
|
Sanabani, Sabri Saeed |
|
|
25 |
2 |
p. e82-e89 |
artikel |
3 |
Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis
|
Okcu, Izel |
|
|
25 |
2 |
p. 116-123 |
artikel |
4 |
Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma
|
Lin, Andrew |
|
|
25 |
2 |
p. e90-e95 |
artikel |
5 |
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort
|
Chalopin, T. |
|
|
25 |
2 |
p. e103-e109.e1 |
artikel |
6 |
Real World Data on Efficacy and Safety of EPOCH in T-Cell Lymphoma
|
Straining, Rachael |
|
|
25 |
2 |
p. e96-e102 |
artikel |
7 |
Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience
|
Soni, Anveshika |
|
|
25 |
2 |
p. e110-e119 |
artikel |
8 |
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma
|
Khare, Somya |
|
|
25 |
2 |
p. e120-e125 |
artikel |
9 |
SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
|
Shmidt, Daniil |
|
|
25 |
2 |
p. 77-88 |
artikel |
10 |
SOHO State of the Art Updates and Next Questions | Covalent Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia
|
Alsouqi, Aseel |
|
|
25 |
2 |
p. 89-95 |
artikel |
11 |
Table of Contents
|
|
|
|
25 |
2 |
p. A3-A5 |
artikel |
12 |
Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
|
Ye, Jing Christine |
|
|
25 |
2 |
p. 124-134.e5 |
artikel |
13 |
The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma
|
Chakrabarti, Ritu |
|
|
25 |
2 |
p. 96-108 |
artikel |
14 |
Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma
|
Fiala, Mark A. |
|
|
25 |
2 |
p. 109-115 |
artikel |
15 |
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)
|
Kastritis, Efstathios |
|
|
25 |
2 |
p. e71-e81 |
artikel |